Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-03

Clinical Trial Update: RICE: Remission by Intra-articular Injection Plus CErtolizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intra-articular injection plus certolizumab (RICE) in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Certolizumab (certolizumab)
  • RICE (R-CHOP-like regimen? (RICE))

Snippet

Sponsor: Rüdiger B. Müller | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED